Quid pro quo at Pfizer?
Ed Silverman has done an interesting interview with the maraviroc whistleblower, on the same day the HIV drug maraviroc was suddenly approved.
You can find the interview here: Pfizer Whistleblower Discusses The Aftermath
The approval of maraviroc comes only a couple of days after Pfizer allegedly terminated three senior executives in the HIV divison, among them the sales director.
Timing is interesting . . . and the question could be posed: Did Pfizer gain approval for maraviroc in return for terminating certain individuals?
More on BranweekNRX.